Dustan E. McCoy
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
YETI Shares React to Upgrade and Revenue Growth. YETI Holdings received an upgrade following strong August revenue results and a raised guidance outlook. The company is also expanding its product line beyond drinkware, which may influence future growth. These developments provide context for the stock's recent trading near support levels.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
LPX Faces Analyst Downgrade and Upcoming Q3 Results. LPX has been highlighted as a trending stock and has posted returns that outpace the broader market, according to recent Yahoo reports. Barclays keeps an overweight rating but lowered its price target to $88, while SeekingAlpha has issued a downgrade, reflecting mixed analyst sentiment. The company will announce its third‑quarter 2026 results on Nov. 3, and the stock is currently near a key support level of $70.24 with an RSI of 43.3, indicating neither overbought nor oversold conditions.
Transaction History
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| YETI | ▲ Buy | Grant | 3,719 | $0 | 5/7/2026 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| LPX | ▲ Buy | Grant | 1,499 | $0 | 5/15/2025 | View on chart |
| YETI | ▲ Buy | Grant | 5,467 | $0 | 5/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| LPX | ▲ Buy | Grant | 1,549 | $0 | 5/17/2024 | View on chart |
| YETI | ▲ Buy | Grant | 4,077 | $0 | 5/7/2024 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| LPX | ▲ Buy | Grant | 2,182 | $0 | 5/5/2023 | View on chart |
| YETI | ▲ Buy | Grant | 2,801 | $0 | 5/4/2023 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| FCX | ▲ Buy | Option Exercise | 10,000 | $321K | 5/31/2022 | View on chart |
| FCX | ▼ Sell | Open Market | 8,200 | $322K | 5/31/2022 | View on chart |
| LPX | ▲ Buy | Option Exercise | 7,635 | $68K | 5/16/2022 | View on chart |
| LPX | ▼ Sell | Tax Withholding | 1,002 | $68K | 5/16/2022 | View on chart |
| YETI | ▲ Buy | Grant | 2,393 | $0 | 5/5/2022 | View on chart |
| LPX | ▲ Buy | Grant | 1,733 | $0 | 5/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.